Dr. Constantinos Hadjipanayis is a neurosurgeon and chair of the neurosurgical oncology department at Mount Sinai/Beth Israel. Dr Hadjipanayis discusses the use of the oral drug Gleolan, an optical imaging agent recently approved by the FDA which fluoresces brain tumors to make them more visible during surgery.
